Histological grading of breast carcinomas: a study of interobserver agreement.
about
Breast cancer in the personal genomics eraAdvances in the Molecular Analysis of Breast Cancer: Pathway Toward Personalized MedicineAutomatic prediction of tumour malignancy in breast cancer with fractal dimensionSpatial and molecular resolution of diffuse malignant mesothelioma heterogeneity by integrating label-free FTIR imaging, laser capture microdissection and proteomicsPrognostic relevance of histological grade and its components in node-negative breast cancer patients.Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.Assessing agreement between multiple raters with missing rating information, applied to breast cancer tumour grading.Tumor tissue protein signatures reflect histological grade of breast cancerInfiltrating breast carcinoma smaller than 0.5 centimeters: is lymph node dissection necessary?Prognostic significance of grading in lung adenocarcinoma.Methylated DNA and high total DNA levels in the serum of patients with breast cancer following neoadjuvant chemotherapy are predictive of a poor prognosis.Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a.Genomic heterogeneity of breast tumor pathogenesisPositive expression of insulin-like growth factor-1 receptor is associated with a positive hormone receptor status and a favorable prognosis in breast cancerPathological features of Breast Cancer seen in Northwestern Tanzania: a nine years retrospective study.A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients.Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancerMuch of the variation in breast pathology quality assurance data in the UK can be explained by the random order in which cases arrive at individual centres, but some true outliers do exist.Breast cancer prognostic classification in the molecular era: the role of histological grade.Preoperative assessment of prognostic factors in breast cancer.Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts.Prognostic value of automatically extracted nuclear morphometric features in whole slide images of male breast cancer.Role of Erbin in ErbB2-dependent breast tumor growth.Morphologic complexity of epithelial architecture for predicting invasive breast cancer survival.Tumour histological grade may progress between primary and recurrent invasive mammary carcinoma.Tumor stress-induced phosphoprotein1 (STIP1) as a prognostic biomarker in ovarian cancerAutomatic nuclei segmentation in H&E stained breast cancer histopathology images.Dual-color fluorescence in situ hybridization reveals an association of chromosome 8q22 but not 8p21 imbalance with high grade invasive breast carcinoma.Evaluation of mitotic activity index in breast cancer using whole slide digital images.Design and multiseries validation of a web-based gene expression assay for predicting breast cancer recurrence and patient survivalInvasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes.D2-40, Podoplanin, and CD31 as a Prognostic Predictor in Invasive Ductal Carcinomas of the BreastDifferential diagnosis of breast cancer using quantitative, label-free and molecular vibrational imagingThe impact of matrix metalloproteinase 2 on prognosis and clinicopathology of breast cancer patients: a systematic meta-analysis.Molecular histopathology by spectrally reconstructed nonlinear interferometric vibrational imaging.Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breastAssociation between histology grade, expression of HsMCM2, and cyclin A in human invasive breast carcinomas.The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer.Pathological diagnosis of columnar cell lesions of the breast: are there issues of reproducibility?Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: relation to tumor phenotype and clinical outcome
P2860
Q24602679-1B105C4B-5B3F-41E9-9F9A-ABB3A68D0BF8Q27001994-2ED87AD9-696B-4D31-A17E-7D73501CB604Q28584419-049D36B0-3070-4055-B4CD-5D2CE4F64C93Q30843287-2A48EC46-4D49-4C18-BFBB-272C5B8DDD04Q33203070-30BB59B7-5250-409B-8CDB-39180A1555F6Q33314445-8FD8D67A-3827-404B-A1F5-76FD7B348351Q33359537-B1031478-EC2F-418B-8094-7DCBAE8EC8FAQ33365644-FDECE055-C91C-4221-BB48-8061C8990CA9Q33634708-D59EE5BA-3DC7-4B35-8AC7-C8136C71107AQ33758236-55986187-B2DA-4386-9D8F-8BAD2678B846Q33778433-705371F5-0F1A-4706-849E-08B6103D3021Q33784406-11DDB215-0E6D-4708-BBB7-C3D9E071E7AAQ33860280-C527A77D-4F0A-44E3-9652-DF75779BE499Q33875800-FB8CB5B1-33BE-4CBD-99AD-1EC90526E476Q33940168-CC245DA2-9D2C-4183-9743-6BCBBBE27AA3Q33996270-2AC18BBF-3BC1-4691-8B16-E9317CA0EF50Q34012047-96E4F969-0827-48F9-8648-E4EC04129FB8Q34015159-03442678-9A7E-4086-B206-AE234444CF82Q34173440-79E308FC-BEEF-483D-82D4-F94E55F90B44Q34197110-095BFFA4-3B84-43AF-8916-3D2230EC3056Q34246413-F283B53B-6660-4F87-B59D-21501B5ECA00Q34382247-6C60C595-68F7-4A0F-940B-CFED7D6729A3Q34408829-91BA5C05-548D-4E75-8E16-7687C6AD96EEQ34506605-7F409998-AE0A-4713-B361-CA5583ECFBD6Q34580038-2D8C9EF0-DA2B-42FD-A965-4D73EE6F26FDQ34611741-8A47F65F-79E1-44A8-8D15-DE5D2F2F5C94Q34906509-D1036120-7D0B-4449-8F04-5F7C2A2FC273Q34923557-82B2B398-5672-4603-BF61-84CA6A8550A7Q35080019-0AF2A151-57AD-45AC-9B65-4FDCB61A8D7CQ35084044-1655E23F-F97A-4B2D-BB6C-4A423475DA4DQ35086250-31C34A75-02AF-4A04-BCF6-D8CF8F4D0DE8Q35142225-3EEAE011-12FC-43B2-8A4D-785AC2CCDA5DQ35145573-31C630EF-DA1F-4BE9-9F14-9EBB4C43E63BQ35225035-072EED64-BDC2-4CB6-8F13-500A8DA778F3Q35543025-2B98315E-BE01-4F60-AAE4-97EA36031AE1Q35571004-3DDD3744-72AB-4D43-8DDE-FAA579AF125FQ35586783-E4593E32-2CAC-4F51-9F05-EB755E13FC1CQ35587582-74C79B3E-9448-4396-B4FD-61D895CD9842Q35588701-AC66E4A9-3A5A-48BB-AD07-9937CE59CE96Q35605873-ADD98DC2-CACB-440C-8A8B-C18F53E4D007
P2860
Histological grading of breast carcinomas: a study of interobserver agreement.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Histological grading of breast carcinomas: a study of interobserver agreement.
@en
type
label
Histological grading of breast carcinomas: a study of interobserver agreement.
@en
prefLabel
Histological grading of breast carcinomas: a study of interobserver agreement.
@en
P2093
P50
P1433
P1476
Histological grading of breast carcinomas: a study of interobserver agreement
@en
P2093
P304
P356
10.1016/0046-8177(95)90010-1
P407
P577
1995-08-01T00:00:00Z